Parmax Pharma Share Price
PARMAX
Live Parmax Pharma Share Price Chart
Parmax Pharma Performance
Days Range
| Previous Close | ₹131.15 |
|---|---|
| Open | ₹132.45 |
| Volume | 2,678 |
| Day's Range | ₹132.45 - ₹132.45 |
|---|---|
| 52W Range | ₹22.60 - ₹132.45 |
| Market Cap | ₹91.11 Cr |
Parmax Pharma Fundamentals
| ROCE(TTM) | -85.76 |
|---|---|
| P/E Ratio (TTM) | -76.12 |
| P/B Ratio | 19.83 |
| Industry P/E | 50.83 |
| Debt to Equity | -1.87 |
| ROE | 67.65 |
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | 6.68 |
| Face Value | 10 |
| ROCE(TTM) | -85.76 |
|---|---|
| P/E Ratio (TTM) | -76.12 |
| P/B Ratio | 19.83 |
| Industry P/E | 50.83 |
| Debt to Equity | -1.87 |
| ROE | 67.65 |
|---|---|
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | 6.68 |
| Face Value | 10 |
Parmax Pharma Financials
| Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|
| Net Sales | 2.53 | 4.33 | 3.31 | 8.22 |
| Expenses | 4.38 | 4.79 | 5.11 | 7.87 |
| Profit before tax | -2.08 | -0.73 | -2.27 | 2.20 |
| Operating Profit | -2.08 | -0.73 | -0.58 | 2.20 |
| Net Profit | -2.08 | -0.73 | -0.58 | 2.20 |
| EPS in Rs | -5.56 | -1.96 | -1.56 | 5.88 |
Parmax Pharma Shareholding Pattern
Promoters
30.80%
Retail And Others
69.20%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Parmax Pharma
Incorporated as a public limited company in Nov.'94, Parmax Pharma (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
PPL set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 tpa.
Its Antibiotic project has been fully implemented from 31st May'97, and the non-Antibiotic products project is under final stage of implementation.
Parent Organisation
Indian Private
Managing Director
Umang Alkesh Gosalia
Founded
1994
NSE Symbol
Top Mutual Funds Invested in Parmax Pharma Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,899.0 -17.00 (-0.89%) | ₹4,55,633.71 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 9,100.0 -150.00 (-1.62%) | ₹2,41,576.41 | 5,636.5 - 9,467.0 |
| Torrent Pharmaceuticals Ltd | 4,857.0 -48.50 (-0.99%) | ₹1,84,478.41 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,385.0 -9.70 (-0.70%) | ₹1,11,888.39 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,120.0 -23.00 (-2.01%) | ₹1,11,820.18 | 835.5 - 1,205.0 |
| Laurus Labs Ltd | 1,840.0 -28.50 (-1.53%) | ₹99,417.45 | 823.1 - 1,949.0 |
Popular Stocks
Parmax Pharma Ltd FAQs
Can I buy Parmax Pharma Ltd (Parmax Pharma Ltd) from Angel One?
Yes, You can buy Parmax Pharma Ltd (Parmax Pharma Ltd) shares by opening a Demat account with Angel One.
How do I buy Parmax Pharma Ltd (Parmax Pharma Ltd) from Angel One?
Parmax Pharma Ltd (Parmax Pharma Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Parmax Pharma Ltd (Parmax Pharma Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Parmax Pharma Ltd (Parmax Pharma Ltd) shares.
1. Direct investment: You can buy Parmax Pharma Ltd (Parmax Pharma Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Parmax Pharma Ltd (Parmax Pharma Ltd) shares.
